Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)

This study has been completed.
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Department of Radiation Oncology, University of Maryland
ClinicalTrials.gov Identifier:
NCT01016938
First received: November 19, 2009
Last updated: April 11, 2016
Last verified: April 2016
Results First Received: December 2, 2015  
Study Type: Observational
Study Design: Time Perspective: Prospective
Condition: Lung Cancer

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Dynamic Lung MRI Lung Tumor Motion and Function

Participant Flow:   Overall Study
    Dynamic Lung MRI  
STARTED     16  
COMPLETED     7  
NOT COMPLETED     9  



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Dynmaic Lung MRI Lung Tumor Motion and Function

Baseline Measures
    Dynmaic Lung MRI  
Number of Participants  
[units: participants]
  16  
Age  
[units: participants]
 
<=18 years     0  
Between 18 and 65 years     5  
>=65 years     11  
Gender  
[units: participants]
 
Female     4  
Male     12  
Region of Enrollment  
[units: participants]
 
United States     16  



  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Number of Participants Whose Tumor Position is Visible Within ~2mm Using Cine-MRI Scans and External Sensors   [ Time Frame: 2 years ]

2.  Secondary:   Number of Participants Whose Tumor Motion Could be Tracked Using Dynamic MRI w/ Contrast Post Radiation   [ Time Frame: 2 years ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Warren D'Souza, PhD, MBA
Organization: Universtity of Maryland School of Medicine
phone: 410-328-7159
e-mail: wdsouza@umm.edu



Responsible Party: Department of Radiation Oncology, University of Maryland
ClinicalTrials.gov Identifier: NCT01016938     History of Changes
Other Study ID Numbers: HP-00043875
Study First Received: November 19, 2009
Results First Received: December 2, 2015
Last Updated: April 11, 2016
Health Authority: United States: Institutional Review Board